sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Clinical Trials Market Size Study, by Sponsor, by Area, by Phase, and Regional Forecasts 2024-2032

Global Clinical Trials Market Size Study, by Sponsor, by Area,...

Home / Categories / Healthcare
Global Clinical Trials Market Size Study, by Sponsor, by Area, by Phase, and Regional Forecasts 2024-2032
Global Clinical Trials Market Size...
Report Code
RO1/103/3084

Publish Date
13/Sep/2024

Pages
200
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table of Contents
Chapter 1. Global Clinical Trials Market Executive Summary
1.1. Global Clinical Trials Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Sponsor
1.3.2. By Area
1.3.3. By Phase
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Clinical Trials Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Clinical Trials Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Funding from Governments and Private Sector
3.1.2. Technological Advancements in Clinical Trials
3.1.3. Rise in Chronic Diseases
3.2. Market Challenges
3.2.1. Ethical Concerns in Outsourced Trials
3.2.2. Patient Recruitment and Retention
3.3. Market Opportunities
3.3.1. Decentralized Trials
3.3.2. Predictive Analytics in Clinical Trials
Chapter 4. Global Clinical Trials Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Clinical Trials Market Size & Forecasts by Sponsor 2022-2032
5.1. Segment Dashboard
5.2. Global Clinical Trials Market: Sponsor Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Industry
5.2.2. Government Organizations
5.2.3. Non-Government Organizations
5.2.4. Others
5.2.5. Associations
Chapter 6. Global Clinical Trials Market Size & Forecasts by Area 2022-2032
6.1. Segment Dashboard
6.2. Global Clinical Trials Market: Area Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Oncology
6.2.2. Infectious Diseases
6.2.3. Metabolic Diseases
6.2.4. Cardiovascular Diseases
6.2.5. Neuroscience
6.2.6. Respiratory Diseases
6.2.7. Others
Chapter 7. Global Clinical Trials Market Size & Forecasts by Phase 2022-2032
7.1. Segment Dashboard
7.2. Global Clinical Trials Market: Phase Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Phase 1
7.2.2. Phase 2
7.2.3. Phase 3
7.2.4. Phase 4
Chapter 8. Global Clinical Trials Market Size & Forecasts by Region 2022-2032
8.1. North America Clinical Trials Market
8.1.1. U.S. Clinical Trials Market
8.1.1.1. Sponsor breakdown size & forecasts, 2022-2032
8.1.1.2. Area breakdown size & forecasts, 2022-2032
8.1.1.3. Phase breakdown size & forecasts, 2022-2032
8.1.2. Canada Clinical Trials Market
8.1.3. Mexico Clinical Trials Market
8.2. Europe Clinical Trials Market
8.2.1. UK Clinical Trials Market
8.2.2. Germany Clinical Trials Market
8.2.3. France Clinical Trials Market
8.2.4. Italy Clinical Trials Market
8.2.5. Rest of Europe Clinical Trials Market
8.3. Asia-Pacific Clinical Trials Market
8.3.1. China Clinical Trials Market
8.3.2. India Clinical Trials Market
8.3.3. Japan Clinical Trials Market
8.3.4. Australia Clinical Trials Market
8.3.5. South Korea Clinical Trials Market
8.3.6. Rest of Asia Pacific Clinical Trials Market
8.4. Latin America Clinical Trials Market
8.4.1. Brazil Clinical Trials Market
8.4.2. Mexico Clinical Trials Market
8.4.3. Rest of Latin America Clinical Trials Market
8.5. Middle East & Africa Clinical Trials Market
8.5.1. Saudi Arabia Clinical Trials Market
8.5.2. South Africa Clinical Trials Market
8.5.3. Rest of Middle East & Africa Clinical Trials Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pharmaceutical Product Development, INC. (Thermo Fisher Scientific, Inc.)
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. ICON plc
9.3.3. Charles River Laboratories International, Inc.
9.3.4. IQVIA
9.3.5. SYNEOS HEALTH
9.3.6. SGS SA
9.3.7. PAREXEL International Corporation
9.3.8. Wuxi AppTec, Inc.
9.3.9. Chiltern International Ltd (Laboratory Corporation of America)
9.3.10. Eli Lilly and Company
9.3.11. Novo Nordisk A/S
9.3.12. Pfizer
9.3.13. Clinipace (Caidya)
9.3.14. Laboratory Corporation of America Holdings
9.3.15. Firma Clinical Research
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com